Allergy/Asthma News

ARS Pharmaceuticals announced its submission of a supplemental new drug application to the FDA for neffy 1 mg for the treatment of type 1 allergic reactions in children who weigh between 33 lb and 66 lb.

Adults with asthma and/or COPD who received 23 text messages about preventer inhaler use over 26 weeks had improved inhaler adherence, according to a poster presented at the European Respiratory Society International Congress.

A Korean study identified a 22% increased risk for seizure among young children who were prescribed first-generation antihistamines, according to findings published in JAMA Network Open.

Patients with asthma on dupilumab saw reduced airway inflammation and mucus plugging beginning at 4 weeks with steady improvements through 24 weeks, according to a study presented at the European Respiratory Society International Congress.

Patients with asthma who used a glucagon-like peptide 1 receptor agonist for weight loss experienced improved asthma control, according to a poster presented at the European Respiratory Society International Congress.

Saving money at an early age is perhaps the simplest and one of the most effective methods to accumulate wealth.

Patients with chronic spontaneous urticaria experienced a marked improvement with Dupixent treatment, according to phase 3 trial results released by Regeneron.

Patients with severe eosinophilic asthma who used depemokimab administered every 6 months experienced a 54% reduction in exacerbations over 52 weeks, according to a study presented at the European Respiratory Society International Congress.

Patients with greater impairment before initiating biologic treatment for asthma had better response across all assessed outcomes, according to a study published in The Journal of Allergy and Clinical Immunology: In Practice.

Even patients with mild asthma sometimes experience acute exacerbations that require visits to the ED or hospitalization, according to a study published in The Journal of Allergy and Clinical Immunology: In Practice.